Analysts forecast a 3.2% year-over-year drop in VTRS Q2 EPS to $0.60 despite revenue growth of 2.5% to $3.67B.
Viatris (VTRS) will release Q2 earnings on August 5 after markets close, with analysts expecting a 3% decline in profits. The consensus EPS estimate stands at $0.60, reflecting a 3.2% year-over-year decrease, while revenue is projected to rise 2.5% to $3.67 billion.
The anticipated drop in earnings highlights ongoing challenges in the generics business, despite modest revenue growth. In the same period last year, Viatris reported higher profitability, underscoring the sector’s margin pressures.
No immediate market reaction details were provided ahead of the release.